7 Boundaries and Invalid Claims · 7.2 Medication Boundary
7.2 Medication Boundary
Canine Fat-Based Metabolism
This page is structured as definition, control variables, causal chain, observable outputs, and boundary, and serves as a canonical definition node in Canine FBM.
Medication Boundary is a structural node in Canine FBM, not a feeding label.
Medication can significantly alter canine metabolic outputs and must be layered from structural variables.
Drug class and dose determine intervention range.
Polypharmacy raises interpretation complexity.
Symptom changes require clinical-marker context.
As input architecture and load conditions change, Medication Boundary shifts long-term scheduling pathways.
When variables converge, Canine FBM is more likely to keep higher fatty-acid contribution, controlled protein energy pressure, and stable body condition.
Under medication effects, the same structure can yield different outputs.
Structural backtrace can provide context but cannot override medication supervision.
This page provides no medication advice.
When veterinary supervision is required, the case enters clinical boundary.